179 related articles for article (PubMed ID: 26558419)
1. Thrombomodulin as an intravascular safeguard against inflammatory and thrombotic diseases.
Ito T; Kakihana Y; Maruyama I
Expert Opin Ther Targets; 2016; 20(2):151-8. PubMed ID: 26558419
[TBL] [Abstract][Full Text] [Related]
2. [The role of thrombomodulin in sepsis-associated DIC].
Ito T
Rinsho Ketsueki; 2016 Apr; 57(4):405-11. PubMed ID: 27169442
[TBL] [Abstract][Full Text] [Related]
3. Thrombomodulin as a Physiological Modulator of Intravascular Injury.
Watanabe-Kusunoki K; Nakazawa D; Ishizu A; Atsumi T
Front Immunol; 2020; 11():575890. PubMed ID: 33042158
[TBL] [Abstract][Full Text] [Related]
4. Effective combination therapy of polymyxin-B direct hemoperfusion and recombinant thrombomodulin for septic shock accompanied by disseminated intravascular coagulation: a historical controlled trial.
Yamato M; Minematsu Y; Fujii J; Mori K; Minato T; Miyagawa S; Fujimura R; Morikage N; Arata Y; Nakano C; Wada A; Ito T
Ther Apher Dial; 2013 Oct; 17(5):472-6. PubMed ID: 24107274
[TBL] [Abstract][Full Text] [Related]
5. Thrombomodulin/activated protein C system in septic disseminated intravascular coagulation.
Ikezoe T
J Intensive Care; 2015; 3(1):1. PubMed ID: 25705426
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro effects of the anticoagulant, thrombomodulin, on the inflammatory response in rodent models.
Hagiwara S; Iwasaka H; Matsumoto S; Hasegawa A; Yasuda N; Noguchi T
Shock; 2010 Mar; 33(3):282-8. PubMed ID: 19536047
[TBL] [Abstract][Full Text] [Related]
7. Comparison of recombinant human thrombomodulin and gabexate mesylate for treatment of disseminated intravascular coagulation (DIC) with sepsis following emergent gastrointestinal surgery: a retrospective study.
Akahoshi T; Sugimori H; Kaku N; Tokuda K; Nagata T; Noda E; Morita M; Hashizume M; Maehara Y
Eur J Trauma Emerg Surg; 2015 Oct; 41(5):531-8. PubMed ID: 26038004
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Thrombomodulin Attenuates Preeclamptic Symptoms by Inhibiting High-Mobility Group Box 1 in Mice.
Oda H; Nagamatsu T; Schust DJ; Cabral H; Miyazaki T; Iriyama T; Kawana K; Osuga Y; Fujii T
Endocrinology; 2021 Apr; 162(4):. PubMed ID: 33406229
[TBL] [Abstract][Full Text] [Related]
9. Clinical Impact of Recombinant Soluble Thrombomodulin for Disseminated Intravascular Coagulation Associated with Severe Acute Cholangitis.
Okuda A; Ogura T; Imanishi M; Miyano A; Nishioka N; Higuchi K
Gut Liver; 2018 Jul; 12(4):471-477. PubMed ID: 29699063
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effect of recombinant thrombomodulin for fulminant hepatic failure.
Kurokohchi K; Imataki O; Kubo F
World J Gastroenterol; 2015 Jul; 21(26):8203-7. PubMed ID: 26185395
[TBL] [Abstract][Full Text] [Related]
11. A novel strategy for hemolytic uremic syndrome: successful treatment with thrombomodulin α.
Honda T; Ogata S; Mineo E; Nagamori Y; Nakamura S; Bando Y; Ishii M
Pediatrics; 2013 Mar; 131(3):e928-33. PubMed ID: 23382444
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic evaluation of recombinant thrombomodulin].
Maruyama I
Nihon Rinsho; 1992 Oct; 50(10):2561-7. PubMed ID: 1333021
[TBL] [Abstract][Full Text] [Related]
13. Human thrombomodulin regulates complement activation as well as the coagulation cascade in xeno-immune response.
Kim H; Hawthorne WJ; Kang HJ; Lee YJ; Hwang JI; Hurh S; Ro H; Jeong JC; Cho B; Yang J; Ahn C
Xenotransplantation; 2015; 22(4):260-72. PubMed ID: 26179123
[TBL] [Abstract][Full Text] [Related]
14. Circulating activated protein C levels are not increased in septic patients treated with recombinant human soluble thrombomodulin.
Arishima T; Ito T; Yasuda T; Yashima N; Furubeppu H; Kamikokuryo C; Futatsuki T; Madokoro Y; Miyamoto S; Eguchi T; Haraura H; Maruyama I; Kakihana Y
Thromb J; 2018; 16():24. PubMed ID: 30275773
[TBL] [Abstract][Full Text] [Related]
15. Recombinant thrombomodulin attenuates hyper-inflammation and glycocalyx damage in a murine model of Streptococcus pneumoniae-induced sepsis.
Watanabe E; Akamatsu T; Ohmori M; Kato M; Takeuchi N; Ishiwada N; Nishimura R; Hishiki H; Fujimura L; Ito C; Hatano M
Cytokine; 2022 Jan; 149():155723. PubMed ID: 34662822
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of recombinant thrombomodulin in controlled contusion spinal cord injury implicates thrombin signaling.
Festoff BW; Ameenuddin S; Santacruz K; Morser J; Suo Z; Arnold PM; Stricker KE; Citron BA
J Neurotrauma; 2004 Jul; 21(7):907-22. PubMed ID: 15307903
[TBL] [Abstract][Full Text] [Related]
17. [Treatment with recombinant thrombomodulin on disseminated intravascular coagulation caused by urinary tract infections; a retrospective comparative study with control cases].
Machioka K; Shigehara K; Kadomoto S; Iwamoto H; Miyagi T; Nakashima T; Namiki M
Hinyokika Kiyo; 2015 Jan; 61(1):1-6. PubMed ID: 25656012
[TBL] [Abstract][Full Text] [Related]
18. Soluble thrombomodulin attenuates sinusoidal obstruction syndrome in rat through suppression of high mobility group box 1.
Nakamura K; Hatano E; Miyagawa-Hayashino A; Okuno M; Koyama Y; Narita M; Seo S; Taura K; Uemoto S
Liver Int; 2014 Nov; 34(10):1473-87. PubMed ID: 24498917
[TBL] [Abstract][Full Text] [Related]
19. Recombinant thrombomodulin alleviates oxidative stress without compromising host resistance to infection in rats infected with methicillin-resistant Staphylococcus aureus.
Ito T; Shrestha B; Kakihana Y; Maruyama I
Sci Rep; 2020 Oct; 10(1):17413. PubMed ID: 33060764
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of recombinant human soluble thrombomodulin in severe postpartum hemorrhage with disseminated intravascular coagulation.
Sugawara J; Suenaga K; Hoshiai T; Sato T; Nishigori H; Nagase S; Yaegashi N
Clin Appl Thromb Hemost; 2013 Sep; 19(5):557-61. PubMed ID: 22496090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
